Amgen Inc (AMGN)
216.93
-0.53
(-0.24%)
USD |
NASDAQ |
May 26, 16:00
217.01
+0.08
(+0.04%)
After-Hours: 20:00
Amgen Revenue (Quarterly): 6.105B for March 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 6.105B |
| December 31, 2022 | 6.839B |
| September 30, 2022 | 6.652B |
| June 30, 2022 | 6.594B |
| March 31, 2022 | 6.238B |
| December 31, 2021 | 6.846B |
| September 30, 2021 | 6.706B |
| June 30, 2021 | 6.526B |
| March 31, 2021 | 5.901B |
| December 31, 2020 | 6.634B |
| September 30, 2020 | 6.423B |
| June 30, 2020 | 6.206B |
| March 31, 2020 | 6.161B |
| December 31, 2019 | 6.197B |
| September 30, 2019 | 5.737B |
| June 30, 2019 | 5.871B |
| March 31, 2019 | 5.557B |
| December 31, 2018 | 6.23B |
| September 30, 2018 | 5.904B |
| June 30, 2018 | 6.059B |
| March 31, 2018 | 5.554B |
| December 31, 2017 | 5.802B |
| September 30, 2017 | 5.773B |
| June 30, 2017 | 5.81B |
| March 31, 2017 | 5.464B |
| Date | Value |
|---|---|
| December 31, 2016 | 5.965B |
| September 30, 2016 | 5.811B |
| June 30, 2016 | 5.688B |
| March 31, 2016 | 5.527B |
| December 31, 2015 | 5.536B |
| September 30, 2015 | 5.723B |
| June 30, 2015 | 5.37B |
| March 31, 2015 | 5.033B |
| December 31, 2014 | 5.331B |
| September 30, 2014 | 5.031B |
| June 30, 2014 | 5.18B |
| March 31, 2014 | 4.521B |
| December 31, 2013 | 5.011B |
| September 30, 2013 | 4.748B |
| June 30, 2013 | 4.679B |
| March 31, 2013 | 4.238B |
| December 31, 2012 | 4.421B |
| September 30, 2012 | 4.319B |
| June 30, 2012 | 4.477B |
| March 31, 2012 | 4.048B |
| December 31, 2011 | 3.973B |
| September 30, 2011 | 3.944B |
| June 30, 2011 | 3.959B |
| March 31, 2011 | 3.706B |
| December 31, 2010 | 3.841B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.557B
Minimum
Mar 2019
6.846B
Maximum
Dec 2021
6.269B
Average
6.218B
Median
Revenue (Quarterly) Benchmarks
| Johnson & Johnson | 24.75B |
| Eli Lilly and Co | 6.96B |
| Merck & Co Inc | 14.49B |
| Pfizer Inc | 18.28B |
| Regeneron Pharmaceuticals Inc | 3.162B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.841B |
| Total Expenses (Quarterly) | 4.184B |
| EPS Diluted (Quarterly) | 5.28 |
| Enterprise Value | 145.95B |
| Gross Profit Margin (Quarterly) | 71.83% |
| Profit Margin (Quarterly) | 46.54% |
| Earnings Yield | 6.78% |
| Operating Earnings Yield | 7.70% |
| Normalized Earnings Yield | 6.781 |